1. Home
  2. PRSU vs FTRE Comparison

PRSU vs FTRE Comparison

Compare PRSU & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$47.33

Market Cap

1.4B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.79

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
FTRE
Founded
1926
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
PRSU
FTRE
Price
$47.33
$17.79
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$31.67
$14.06
AVG Volume (30 Days)
206.8K
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,064,987,000.00
$2,723,400,000.00
Revenue This Year
$4.85
N/A
Revenue Next Year
$4.94
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
9.48
1.00
52 Week Low
$32.03
$7.40
52 Week High
$56.52
$21.39

Technical Indicators

Market Signals
Indicator
PRSU
FTRE
Relative Strength Index (RSI) 38.11 46.68
Support Level $32.90 $17.37
Resistance Level $54.24 $17.81
Average True Range (ATR) 1.87 1.33
MACD -0.63 -0.20
Stochastic Oscillator 25.62 6.04

Price Performance

Historical Comparison
PRSU
FTRE

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: